And yes we_老虎社区_美港股上老虎

XLMM
2022-01-12

And yes we have one of them today...South Korea! Yay!

Novavax COVID-19 vaccine could be cleared in multiple countries: CEO Stanley Erck

On Monday, Stanley Erck, the CEO of Novavax said he expects the company's coronavirus vaccine could

Novavax COVID-19 vaccine could be cleared in multiple countries: CEO Stanley Erck

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":694641100,"tweetId":"694641100","gmtCreate":1641969883226,"gmtModify":1641969883316,"author":{"id":4100909250192760,"idStr":"4100909250192760","authorId":4100909250192760,"authorIdStr":"4100909250192760","name":"XLMM","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>And yes we have one of them today...South Korea! Yay!</p></body></html>","htmlText":"<html><head></head><body><p>And yes we have one of them today...South Korea! Yay!</p></body></html>","text":"And yes we have one of them today...South Korea! Yay!","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/694641100","repostId":1192824861,"repostType":2,"repost":{"id":"1192824861","kind":"news","pubTimestamp":1641897395,"share":"https://www.laohu8.com/m/news/1192824861?lang=&edition=full","pubTime":"2022-01-11 18:36","market":"us","language":"en","title":"Novavax COVID-19 vaccine could be cleared in multiple countries: CEO Stanley Erck","url":"https://stock-news.laohu8.com/highlight/detail?id=1192824861","media":"Seeking Alpha","summary":"On Monday, Stanley Erck, the CEO of Novavax  said he expects the company's coronavirus vaccine could","content":"<html><head></head><body><p>On Monday, Stanley Erck, the CEO of <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> said he expects the company&#39;s coronavirus vaccine could be cleared for use in multiple countries, including U.S., in coming months.</p><p>The U.S. vaccine maker has filed for emergency approval with 10 different regulatory agencies. “I expect in the next 90 days we could have all 10 of them,” Erck said.</p><p>On Dec. 31, Novavax submitted its final data package to the FDA. It has yet to file the full application for emergency use authorization, but will do so shortly and expects a decision from American regulators in February.</p><p>Erck didn’t name the other regulatory agencies, but according to the company site, it has recently applied for approval in Japan, the UAE, Singapore, New Zealand, Canada, Australia, South Africa and the U.K.</p><p>Several other health agencies across the globe have already given their nod of approval to the vaccine.</p><p>Also, on Monday, Pfizer (NYSE:PFE) CEO Albert Bourla said two doses of the company’s vaccine may not provide strong protection against Omicron COVID variant, and the original shots have also lost some of their efficacy at preventing hospitalization.</p><p>In an interview at J.P. Morgan’s healthcare conference, Bourla emphasized the importance of a third shot to boost people’s protection against Omicron.</p><p>“The two doses, they’re not enough for omicron,” Bourla said. “The third dose of the current vaccine is providing quite good protection against deaths, and decent protection against hospitalizations.”</p><p>Earlier, Pfizer CEO said that the company will have an Omicron targeting vaccine ready in March, though he said it’s not clear whether it will be needed or not.</p><p>Bourla also said he didn&#39;t know if a fourth vaccine shot would be needed but that the possibility should be studied in order to discover the best possible way to fight against the virus.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax COVID-19 vaccine could be cleared in multiple countries: CEO Stanley Erck</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax COVID-19 vaccine could be cleared in multiple countries: CEO Stanley Erck\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-11 18:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3786944-novavax-covid-19-vaccine-could-be-cleared-in-multiple-countries-in-90-days-ceo-stanley-erck><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On Monday, Stanley Erck, the CEO of Novavax  said he expects the company's coronavirus vaccine could be cleared for use in multiple countries, including U.S., in coming months.The U.S. vaccine maker ...</p>\n\n<a href=\"https://seekingalpha.com/news/3786944-novavax-covid-19-vaccine-could-be-cleared-in-multiple-countries-in-90-days-ceo-stanley-erck\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3786944-novavax-covid-19-vaccine-could-be-cleared-in-multiple-countries-in-90-days-ceo-stanley-erck","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192824861","content_text":"On Monday, Stanley Erck, the CEO of Novavax  said he expects the company's coronavirus vaccine could be cleared for use in multiple countries, including U.S., in coming months.The U.S. vaccine maker has filed for emergency approval with 10 different regulatory agencies. “I expect in the next 90 days we could have all 10 of them,” Erck said.On Dec. 31, Novavax submitted its final data package to the FDA. It has yet to file the full application for emergency use authorization, but will do so shortly and expects a decision from American regulators in February.Erck didn’t name the other regulatory agencies, but according to the company site, it has recently applied for approval in Japan, the UAE, Singapore, New Zealand, Canada, Australia, South Africa and the U.K.Several other health agencies across the globe have already given their nod of approval to the vaccine.Also, on Monday, Pfizer (NYSE:PFE) CEO Albert Bourla said two doses of the company’s vaccine may not provide strong protection against Omicron COVID variant, and the original shots have also lost some of their efficacy at preventing hospitalization.In an interview at J.P. Morgan’s healthcare conference, Bourla emphasized the importance of a third shot to boost people’s protection against Omicron.“The two doses, they’re not enough for omicron,” Bourla said. “The third dose of the current vaccine is providing quite good protection against deaths, and decent protection against hospitalizations.”Earlier, Pfizer CEO said that the company will have an Omicron targeting vaccine ready in March, though he said it’s not clear whether it will be needed or not.Bourla also said he didn't know if a fourth vaccine shot would be needed but that the possibility should be studied in order to discover the best possible way to fight against the virus.","news_type":1},"isVote":1,"tweetType":1,"viewCount":752,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["AONE.U"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":44,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}